Cancer is a condition where cells in a certain part of the body grow and begin to reproduce uncontrollably. As the cancer advances it begins to destroy surrounding tissue and organs. With more than one in three people developing some form of cancer during their lifetime in the UK, and with there being no cure, recognising the symptoms as early on as possible is the key to survival. One symptom which could be overlooked, particular as the weather gets warmer, can occur during sleep.
Avacta Group Plc (LON:AVCT) principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.